surmount 4 tirzepatide Time to weight plateau with treatment in the SURMOUNT‐1 and SURMOUNT‐4 clinical trials - Horn - 2025 - Clinical Obesity SURMOUNT‐1 study design. This is

Making the right decision for you Here's the bottom line: the decision about semaglutide during breastfeeding isn't black and white

What to Expect: Noticeable changes in your weight, energy levels, and overall confidence

10.1186/s12933-022-01604-7 35 NiY.QianL.SiliceoS

However, the FDA has expressed concern about some compounded versions of semaglutide using ingredients like semaglutide sodium or acetate, which are not listed on the FDAs approved drug shortage list and haven't been evaluated for safety or efficacy in compounded use

doi: 10.1038/s41366-025-01859-6 160 TzangC-CWuP-HLuoC-AChenZ-TLeeY-THuangESet al

It is the question we have been pointing at the whole time: which molecule fits which biology, in which patient, optimizing for which axis